| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |